MVision AI

MVision AI is launching Dose+, expanding AI capabilities in radiation therapy. Dose+ is an AI-powered dose prediction technology that supports radiation therapy professionals during treatment planning. By providing patient-specific dose predictions, it helps to guide plan optimisation for prostate and pelvic lymph node radiation therapy. The key benefits of Dose+: • CLINICALLY GUIDED – Assists radiation therapy professionals by generating patient-specific dose predictions from CT scans and outlined structures. • SEAMLESS INTEGRATION – Works with any DICOM-compliant treatment planning system and integrates smoothly into existing workflows without requiring additional installation. • CONSISTENCY AND UNIFORMITY – AI-generated dose predictions provide a strong starting point for optimisation objectives definition, helping maintain uniformity across cases without requiring site-specific fine-tuning. Tested across real-world clinical environments in Europe and North America, Dose+ has demonstrated significant efficiency and reliability, supporting clinicians in developing high-quality, personalised patient care. We are pleased to offer clinicians this enhanced AI-driven capability to support treatment planning. Read the press release here: https://lnkd.in/d9MnFN9m *Dose+ is CE Marked (Under MDR) and FDA 510(k) pending. Not available for sale in all regions #AIinRadiotherapy #RadiationTherapy #MVisionAI #DosePrediction

✨We celebrated International Women’s Day at the office today, taking a moment to recognize and appreciate the incredible women who contribute to our team’s success. We are proud to support and empower the women in our organization, acknowledging their hard work, leadership, and dedication. As we celebrate today, we remain committed to fostering an environment where everyone has the opportunity to thrive 💜 #InternationalWomensDay #WomenInTheWorkplace

📢 MVision AI supports innovation in AI-driven radiotherapy! As one of the sponsors of the Bern AI in Radiotherapy (BART) Symposium on March 14, 2025, at the University of Bern, we’re supporting an event that brings together researchers, clinicians, and AI engineers to explore the latest breakthroughs in AI for radiation therapy. BART fosters collaboration between industry, academia, and clinics, bridging the gap between cutting-edge technology and patient care. With discussions on AI-driven treatment planning, predictive modelling, and image-guided radiotherapy, it provides an important platform for advancing AI’s role in cancer treatment. We’re excited to support this initiative and the important conversations happening at #BART! #AIinRadiotherapy #MedicalAI #RadiationTherapy #CancerCare

🚀 Exciting news from MVision AI! We are thrilled to announce that MVision AI’s MR-based segmentation models have received market approval from the Therapeutic Goods Administration (TGA) in Australia. This milestone paves the way for clinicians to integrate AI-powered MRI segmentation into radiotherapy treatment planning. By leveraging the power of AI-driven segmentation, clinicians can deliver consistent, reliable, and more personalised patient care. We look forward to continuing our work with alphaXRT to expand these tools across Australia and New Zealand. Here’s to advancing cancer care together! 👉 https://bit.ly/4k83Vs2 #RadiationOncology #AIinHealthcare #TGAApproval

Today, on World Cancer Day, we come together to raise awareness about the importance of cancer prevention, early detection, and treatment. According to the World Health Organization (WHO), cancer remains the leading cause of death globally, accounting for nearly 10 million deaths in 2022. This year’s theme, "United by Unique," emphasizes the critical value of personalized care for cancer patients. At MVision, we are proud to empower radiation oncology professionals with cutting-edge technologies, enabling them to deliver faster, high-quality treatment plans and save more lives in the fight against cancer. #WorldCancerDay #CancerAwareness #PersonalizedCare #Oncology #HealthcareInnovation

We're #hiring a new Marketing Specialist in Greater London, England. Apply today or share this post with your network.

On behalf of everyone at MVision AI, we wish our community, valued customers, partners and colleagues a Happy Chinese New Year and Lantern Festival filled with happiness, health and success! As we welcome this season of renewal and fresh beginnings, we are honored, excited and inspired to continue this journey with you! https://mvision.ai/ #MVisionAICommunity #WeCelebrate

Our new website is now live and ready to make your journey on mvision.ai smoother and more inspiring! What’s new? - Simplified navigation to quickly access what matters most. - A fresh design that makes your experience pleasant and seamless. - Insightful content that’s now easier to explore and enjoy. We’d love for you to take a look, explore and let us know what you think! And don’t forget to sign up for our newsletter to stay connected with all the latest updates. Visit now: https://mvision.ai/ #MVisionAI #NewWebsite #NewChapter

We’re kicking off the end-of-year celebrations with some exciting news! MVision AI is proud to share that Contour+ has successfully transitioned from the EU Medical Devices Directive (MDD) to the new, more stringent EU Medical Device Regulation (MDR). This transition is a crucial step for us, ensuring that our products meet the highest standards of safety, performance and quality. Under MDD, medical devices were subject to specific standards, but MDR introduces stricter requirements in areas like clinical evaluation, post-market surveillance and traceability. For MVision AI, this move strengthens Contour+'s reliability and trustworthiness, ensuring that we continue to meet evolving regulatory requirements and provide the best solutions in radiation therapy. Here’s to a fast start in 2025 and many more milestones ahead! To read the full press release: https://bit.ly/41QCWuj #MDRCertification #RadiationOncology #NewYearNewMilestones

Our dear MVision AI community, valued customers, partners and colleagues, thank you for the incredible milestones we’ve achieved together in 2024. We feel fortunate to work alongside such visionary professionals who share our commitment to making a real difference in the world! On behalf of everyone at MVision AI, we wish you and your loved ones a Merry Christmas, happy holidays and a New Year filled with peace, health and endless possibilities. We are excited to continue this journey with you in 2025 and beyond — together, stronger and more determined than ever! https://mvision.ai/ #MVisionAI #SeasonsGreetings #HappyHolidays